Author:
Huang Xuan,Shu Qing,Luo Xuemei,Ge Weihong,Xie Han,Zhou Yujie
Funder
Jiangsu Research Hospital Association
Jiangsu Pharmaceutical Association
Publisher
Springer Science and Business Media LLC
Subject
Immunology and Allergy,Rheumatology
Reference32 articles.
1. Al-Rawi H, Meggitt SJ, Williams FM, et al. Steady-state pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus. Lupus. 2018;27:847–52.
2. Durcan L, Clarke WA, Magder LS, et al. Hydroxychloroquine blood levels in SLE: clarifying dosing controversies and improving adherence. J Rheumatol. 2015;42:2092–7.
3. Li M, Zhao Y, Zhang Z, et al. 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus. Rheumatol Immunol Res. 2020;1:5–23.
4. Tett SE, Cutler DJ, Beck C, et al. Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis–a prospective, dose ranging study. J Rheumatol. 2000;27:1656–60.
5. Zhong X, Jin Y, Zhang Q, et al. Low estimated glomerular filtration rate is an independent risk factor for higher hydroxychloroquine concentration. Clin Rheumatol. 2023;42:1943–50.